<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<?xml-stylesheet type="text/xsl" href="/css/apdocuments/ap-case.xsl"?>
<apCase>
  <creationDate>2019-04-05</creationDate>
  <apCaseHeader>
    <fileNumbers>
      <fileNumber>3-18691</fileNumber>
    </fileNumbers>
    <respondents>
      <respondent>Equilar Capital Corp.</respondent>
      <respondent>Neuro-Biotech Corporation</respondent>
    </respondents>
    <caseLink>/litigation/apdocuments/ap-3-18691.xml</caseLink>
  </apCaseHeader>
  <releaseItem>
    <date>2018-08-28</date>
    <releaseNumber>34-83978</releaseNumber>
    <otherReleaseNumbers />
    <title>Order Instituting Administrative Proceedings and Notice of Hearing Pursuant to Section 12(j) of the Securities Exchange Act of 1934</title>
    <secLink>/litigation/admin/2018/34-83978.pdf</secLink>
  </releaseItem>
  <releaseItem>
    <date>2018-11-30</date>
    <releaseNumber>34-84708</releaseNumber>
    <otherReleaseNumbers />
    <title>Order to Show Cause</title>
    <secLink>/litigation/opinions/2018/34-84708.pdf</secLink>
  </releaseItem>
  <releaseItem>
    <date>2019-04-04</date>
    <releaseNumber>34-85510</releaseNumber>
    <otherReleaseNumbers />
    <title>Opinion of the Commission</title>
    <secLink>/litigation/opinions/2019/34-85510.pdf</secLink>
  </releaseItem>
</apCase>